Stentys Reports First Quarter 2015 Revenues Rose 28%
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing the world's first and only Self-Apposing® coronary stent, today announces revenues for the first quarter of 2015.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.